Long-Term Outcomes of a Phase 2 Trial of Chemotherapy With Consolidative Radiation Therapy for Oligometastatic Non-Small Cell Lung Cancer

Por Petty, W. Jeffrey, Urbanic, James J., Ahmed, Tamjeed, Hughes, Ryan, Levine, Beverly, Rusthoven, Kyle, Papagikos, Michael, Ruiz, Jimmy R., Lally, Brian E., Chan, Michael, Clark, Hollins, D’Agostino, Ralph B., Blackstock, A. William
Publicado no Int J Radiat Oncol Biol Phys (2018)

Regorafenib in Patients with Antiangiogenic‐Naïve and Chemotherapy‐Refractory Advanced Colorectal Cancer: Results from a Phase IIb Trial

Por Riechelmann, Rachel P., Leite, Luiz S., Bariani, Giovanni M., Glasberg, Joao, Rivelli, Thomas G., da Fonseca, Leonardo Gomes, Nebuloni, Daniela R., Braghiroli, Maria I., Queiroz, Marcelo A., Isejima, Alice M., Kappeler, Christian, Kikuchi, Luciana, Hoff, Paulo M.
Publicado no Oncologist (2019)

RUBY-1: a randomized, double-blind, placebo-controlled trial of the safety and tolerability...

Por Steg, Ph. Gabriel, Mehta, Shamir R., Jukema, J. Wouter, Lip, Gregory Y.H., Gibson, C. Michael, Kovar, Frantisek, Kala, Petr, Garcia-Hernandez, Alberto, Renfurm, Ronny W., Granger, Christopher B.
Publicado em 2011

A randomized, double‐blind, placebo‐controlled, dose‐finding trial with Lolium perenne peptide immunotherapy

Por Mösges, R., Kasche, E. M., Raskopf, E., Singh, J., Sohlich, L., Astvatsatourov, A., Shah‐Hosseini, K., Pirotton, S., Haazen, L., Durham, S. R., Legon, T., Zadoyan, G., Shamji, M. H.
Publicado no Allergy (2017)

ERS Special Article. Efficacy and Safety of High-Dose Rifampin in Pulmonary Tuberculosis. A Randomized Controlled Trial

Por Velásquez, Gustavo E., Brooks, Meredith B., Coit, Julia M., Pertinez, Henry, Vargas Vásquez, Dante, Sánchez Garavito, Epifanio, Calderón, Roger I., Jiménez, Judith, Tintaya, Karen, Peloquin, Charles A., Osso, Elna, Tierney, Dylan B., Seung, Kwonjune J., Lecca, Leonid, Davies, Geraint R., Mitnick, Carole D.
Publicado no Am J Respir Crit Care Med (2018)

A randomized non-comparative phase II trial of cixutumumab (IMC-A12) or ramucirumab (IMC-1121B...

Por Hussain, Maha, Rathkopf, Dana, Liu, Glenn, Armstrong, Andrew, Kelly, Wm. Kevin, Ferrari, Anna, Hainsworth, John, Joshi, Adarsh, Hozak, Rebecca R., Yang, Ling, Schwartz, Jonathan D., Higano, Celestia S.
Publicado no Eur J Cancer (2015)

Phase III Study of Adjuvant Ipilimumab (3 or 10 mg/kg) Versus High-Dose Interferon Alfa-2b for Resected High-Risk Melanoma: North American Intergroup E1609

Por Tarhini, Ahmad A., Lee, Sandra J., Hodi, F. Stephen, Rao, Uma N. M., Cohen, Gary I., Hamid, Omid, Hutchins, Laura F., Sosman, Jeffrey A., Kluger, Harriett M., Eroglu, Zeynep, Koon, Henry B., Lawrence, Donald P., Kendra, Kari L., Minor, David R., Lee, Carrie B., Albertini, Mark R., Flaherty, Lawrence E., Petrella, Teresa M., Streicher, Howard, Sondak, Vernon K., Kirkwood, John M.
Publicado no J Clin Oncol (2020)

Clinical Outcomes of Transplanted Modified Bone Marrow–Derived Mesenchymal Stem Cells in Stroke: A Phase 1/2a Study

Por Steinberg, Gary K., Kondziolka, Douglas, Wechsler, Lawrence R., Lunsford, L. Dade, Coburn, Maria L., Billigen, Julia B., Kim, Anthony S., Johnson, Jeremiah N., Bates, Damien, King, Bill, Case, Casey, McGrogan, Michael, Yankee, Ernest W., Schwartz, Neil E.
Publicado no Stroke (2016)

Randomized Phase II Trial of Gemcitabine Plus TH-302 Versus Gemcitabine in Patients With Advanced Pancreatic Cancer

Por Borad, Mitesh J., Reddy, Shantan G., Bahary, Nathan, Uronis, Hope E., Sigal, Darren, Cohn, Allen L., Schelman, William R., Stephenson, Joe, Chiorean, E. Gabriela, Rosen, Peter J., Ulrich, Brian, Dragovich, Tomislav, Del Prete, Salvatore A., Rarick, Mark, Eng, Clarence, Kroll, Stew, Ryan, David P.
Publicado no J Clin Oncol (2015)

Totally implantable venous power ports of the forearm and the chest: initial clinical experience with port devices approved for high-pressure injections

Por Goltz, J P, Noack, C, Petritsch, B, Kirchner, J, Hahn, D, Kickuth, R
Publicado em 2012

Organ Preservation in Rectal Adenocarcinoma: a phase II randomized controlled trial evaluating 3...

Por Smith, J. Joshua, Chow, Oliver S., Gollub, Marc J., Nash, Garrett M., Temple, Larissa K., Weiser, Martin R., Guillem, José G., Paty, Philip B., Avila, Karin, Garcia-Aguilar, Julio
Publicado no BMC Cancer (2015)

Extrapolating theoretical efficacy of inactivated influenza A/H5N1 virus vaccine from human immunogenicity studies

Por Feldstein, Leora R., Matrajt, Laura, Halloran, M. Elizabeth, Keitel, Wendy A., Longini, Ira M.
Publicado no Vaccine (2016)

A phase III randomised controlled trial of erlotinib vs gefitinib in advanced non-small cell lung cancer with EGFR mutations

Por Yang, J J, Zhou, Q, Yan, H H, Zhang, X C, Chen, H J, Tu, H Y, Wang, Z, Xu, C R, Su, J, Wang, B C, Jiang, B Y, Bai, X Y, Zhong, W Z, Yang, X N, Wu, Y L
Publicado no Br J Cancer (2017)

Phase 1b study of venetoclax-obinutuzumab in previously untreated and relapsed/refractory chronic lymphocytic leukemia

Por Flinn, Ian W., Gribben, John G., Dyer, Martin J. S., Wierda, William, Maris, Michael B., Furman, Richard R., Hillmen, Peter, Rogers, Kerry A., Iyer, Swaminathan Padmanabhan, Quillet-Mary, Anne, Ysebaert, Loic, Walter, Harriet S., Verdugo, Maria, Klein, Christian, Huang, Huang, Jiang, Yanwen, Lozanski, Gerard, Pignataro, Daniela Soriano, Humphrey, Kathryn, Mobasher, Mehrdad, Kipps, Thomas J.
Publicado no Blood (2019)

Venetoclax plus R- or G-CHOP in non-Hodgkin lymphoma: results from the CAVALLI phase 1b trial

Por Zelenetz, Andrew D., Salles, Gilles, Mason, Kylie D., Casulo, Carla, Le Gouill, Steven, Sehn, Laurie H., Tilly, Herve, Cartron, Guillaume, Chamuleau, Martine E. D., Goy, Andre, Tam, Constantine S., Lugtenburg, Pieternella J., Petrich, Adam M., Sinha, Arijit, Samineni, Divya, Herter, Sylvia, Ingalla, Ellen, Szafer-Glusman, Edith, Klein, Christian, Sampath, Deepak, Kornacker, Martin, Mobasher, Mehrdad, Morschhauser, Franck
Publicado no Blood (2019)

Efficacy of certolizumab pegol on signs and symptoms of axial spondyloarthritis including ankylosing spondylitis: 24-week results of a double-blind randomised placebo-controlled Phase 3 study

Por Landewé, R, Braun, J, Deodhar, A, Dougados, M, Maksymowych, W P, Mease, P J, Reveille, J D, Rudwaleit, M, van der Heijde, D, Stach, C, Hoepken, B, Fichtner, A, Coteur, G, de Longueville, M, Sieper, J
Publicado em 2014

A Randomized Phase 2 Trial of Gemcitabine/Cisplatin With or Without Cetuximab in Patients With Advanced Urothelial Carcinoma

Por Hussain, Maha, Daignault, Stephanie, Agarwal, Neeraj, Grivas, Petros D., Siefker-Radtke, Arlene O., Puzanov, Igor, MacVicar, Gary R., Levine, Ellis Glenn, Srinivas, Sandy, Twardowski, Przemyslaw, Eisenberger, Mario A., Quinn, David I., Vaishampayan, Ulka N., Yu, Evan Y., Dawsey, Scott, Day, Kathleen C., Day, Mark L., Al-Hawary, Mahmoud, Smith, David C.
Publicado em 2014

Bevacizumab+chemotherapy versus chemotherapy alone in elderly patients with untreated metastatic colorectal cancer: a randomized phase II trial—PRODIGE 20 study results

Por Aparicio, T, Bouché, O, Taieb, J, Maillard, E, Kirscher, S, Etienne, P -L, Faroux, R, Khemissa Akouz, F, El Hajbi, F, Locher, C, Rinaldi, Y, Lecomte, T, Lavau-Denes, S, Baconnier, M, Oden-Gangloff, A, Genet, D, Paillaud, E, Retornaz, F, François, E, Bedenne, L
Publicado no Ann Oncol (2018)

Immunotherapeutic maintenance treatment with toll-like receptor 9 agonist lefitolimod in patients with extensive-stage small-cell lung cancer: results from the exploratory, controlled, randomized, international phase II IMPULSE study

Por Thomas, M, Ponce-Aix, S, Navarro, A, Riera-Knorrenschild, J, Schmidt, M, Wiegert, E, Kapp, K, Wittig, B, Mauri, C, Dómine Gómez, M, Kollmeier, J, Sadjadian, P, Fröhling, K -P, Huber, R M, Wolf, M
Publicado no Ann Oncol (2018)

A phase II randomized trial of induction chemotherapy versus no induction chemotherapy followed...

Por Ajani, J. A., Xiao, L., Roth, J. A., Hofstetter, W. L., Walsh, G., Komaki, R., Liao, Z., Rice, D. C., Vaporciyan, A. A., Maru, D. M., Lee, J. H., Bhutani, M. S., Eid, A., Yao, J. C., Phan, A. P., Halpin, A., Suzuki, A., Taketa, T., Thall, P. F., Swisher, S. G.
Publicado em 2013